{"name":"Technoderma Medicines Inc.","slug":"technoderma-medicines-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TDM-105795","genericName":"TDM-105795","slug":"tdm-105795","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"TDM-105795","genericName":"TDM-105795","slug":"tdm-105795","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxPUzFaNHMwNzJVOTBVblRHdE1SbWE1UW4zVHBFMzc4N0tENmdpODBxdVo0eVR4ZXFLb1VhdW14M1pqOVVaRTNlRDlrNTR2ZVZLMFYxQXJibUk3dVhVS0hPdDF3TmVHd25EOGlOUC1jemotWEZCNXQ2cldvZnlBc3dvcXNja3N0OU9nT2l6X3d1cDF5bFFPVFlSeG9zUm5xUDBqcEQyTjNnMWdRb1N3Z2hyMEREY2p4T3BkRmVpM05TVnAtU1FSdE5Ra2VXWmN6dUhEUlFuYnUxTGgxYndaTFdFVGVoVUpZblVkWWcxQXV3WkFnY3YzUkpSQ090UERZdkVmeEd5ZllHcVliaTE0WXJ4RTZvREVtbWkxSVVPQnhjMHJ0Mm5mQzR3QXROZXNvOEtYUzR6dHBOYmZlcnc?oc=5","date":"2026-02-19","type":"pipeline","source":"PR Newswire","summary":"Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight - PR Newswire","headline":"Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNYkwtUmVWVDJtNWdpTlFJSDJRbGExc1QzUjg4MXQ5SnNGenNoS093VElqb192dFV1UVNyZkxkVWhtSjdDUmVKd2Ruc3ZPZGJVOUVlXzJYXzJEbkducWJ4MFBmejNnV0JpR0xRSHNQQlpNclNxOXIyNWFWX3FrQ3lyRVA2TUtaZnJKMnppVF8xaGFYWHBXenZRUlprS1RkVnZfZlBFZnlINzY0WjQzZW5OV1R5eTJJU0kzSkZrcHdkdw?oc=5","date":"2025-12-07","type":"trial","source":"Genetic Engineering and Biotechnology News","summary":"StockWatch: Cosmo Surges 40% on Baldness Candidate’s Phase III Data - Genetic Engineering and Biotechnology News","headline":"StockWatch: Cosmo Surges 40% on Baldness Candidate’s Phase III Data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQdnZ4UEJpaTMwazZtbm93QjFYOHFmNWVsM3BCYkliNDA2T2dHSElCZW5CczFuVklUQWVXOHVoMkdIMFNfNklYRHF3bUh1ZWx4ZDhZUUNMeXNvek5aWnM3Zks3WGNMOVFsSVRhbnhlYnotWHBQRHlSMmlfeVY0Q0FBTzJLZ3ZCMmU2bjE1X0IxM1dzMkEwa0tYVjFLUE1GNWZnUGFnektBbW14c0pYWnc?oc=5","date":"2025-02-11","type":"trial","source":"Clinical Trials Arena","summary":"Q32 Bio halts trials amid job cuts and pivots to alopecia treatment - Clinical Trials Arena","headline":"Q32 Bio halts trials amid job cuts and pivots to alopecia treatment","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxPVjk4aXE2OUNMbzRLZmRBV1RYVGxsTFJRVHZSVGRhTlVVcG9FM0dvMENpYzZLNWM1d0EzYV9wbTJ4T2d5U0szMUhZb2UyWlFsLTZpdDNFVHJ6cmpYQm5JWW1ZV2hWQlJ0WV91cGFXLTk2M1RSeExYNkJCRmt2VmlyMGV6aDFVdU4xaGFySEtiQlJodWN4NGZuT01rNjZ4TDNZUFhIc3J0azhVek5uWXlGQTlGdU5nZi1Ma3ZQSl8xcWNpcUF0UC13YVA3cG5FeWJXLUxGV0wyZ2FVWTAxb09aSUQxZzMwSmNyYjdNUzJhblZGNlk?oc=5","date":"2025-01-30","type":"pipeline","source":"BioSpace","summary":"Hair Diseases Market Size to Reach USD 13.0 Billion by 2035, Impelled by the Increasing Prevalence of Autoimmune Diseases - BioSpace","headline":"Hair Diseases Market Size to Reach USD 13.0 Billion by 2035, Impelled by the Increasing Prevalence of Autoimmune Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQbVRySHVGS2Z4bVVMbTU0Wkx0M21DRWdUZGF3ZnlkV3o1OGpwNUxjV0xHY29LZTQ4bEJiLU1rQkV0RHY0YmpiWUJUQ182a3U1bG5ocnZTWDBsaEVhTXRqMXIzMzhaYmVXMWFsdC1odkdRVWpvT2wwN2V3ZzdZX1FkN2JTSUxNS3RXLXh0S3BmTmt3QjhwYWxUQXpDYkUzM3AxZk0tVUhLcmw4a1N5elc4MllQUWhnSkhBZWhTekxBOVRfV3ZnTmQwM0RPaEJZY3pfekRv?oc=5","date":"2025-01-07","type":"trial","source":"BioPharma APAC","summary":"Technoderma Medicines Announces Positive Phase 2a Results for TDM-180935 in Atopic Dermatitis - BioPharma APAC","headline":"Technoderma Medicines Announces Positive Phase 2a Results for TDM-180935 in Atopic Dermatitis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1yRG82NllId0FLeThkNWVuM3Q1Y1l4TjA0Zm1LN1JuZFhxV1cyeVZRSGFfT1NiOTl3TVVueEt1TGZ4a3EwSHRDMXBxU0ZkUUZQZXdIWEpBY3B2N3pQbUMtLUVhazhIQnhBS3AySlRLVThyVG50SGdWeA?oc=5","date":"2024-04-30","type":"trial","source":"Clinical Trials Arena","summary":"Technoderma begins dosing in atopic dermatitis therapy trial - Clinical Trials Arena","headline":"Technoderma begins dosing in atopic dermatitis therapy trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOcXRqVXF5ZHpGMkhCZmd1UG0tU3ItSkNHS0tZbmhtbUlzeUNMOWRrbWotalM2SlZscXpQaTJGaUlQcjBTN3hpbk05bEMyYkVBOUNLUWhvQ05nbzBtWXloRXRBWUdHOU9TVFRuR1c5NnpMTlJ0REVvZHRqdV9NMFVZbG9hNjhvWnFZLVpTeTRtN2lmeGJJeWJhRHZGN1hMQQ?oc=5","date":"2024-03-06","type":"pipeline","source":"Stock Titan","summary":"Latest Updates of Viva Biotech's Portfolio Companies - Stock Titan","headline":"Latest Updates of Viva Biotech's Portfolio Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbE1Gd3VFaXNqbFFfYnk1ZVpKNkYySlJvUHV2SEplM0NJQllPMzNZVXR5MEVUVDA0dXZ3cldkZWJBNDRNQ25PalUxOHZyM3d6ODdxclFpRWdRZmMtcXplU2trbk9MR0QwNXBGR1dNUld2QnplNWJVcEljMUpDaGZCNzA2WWZEX2Ns?oc=5","date":"2024-02-06","type":"trial","source":"Clinical Trials Arena","summary":"Technoderma reports data from androgenetic alopecia drug trial - Clinical Trials Arena","headline":"Technoderma reports data from androgenetic alopecia drug trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOTC03R09scjc4NGRUemN0WExfc2RvdGhCbF9Ld2ZkVmlKZXp0RzM0VUxKMkxZcWxoaF9wN01PZHc0aVhWcC1LM3M2bWFZX0hNY0c3bTBPYW5oRVNGNlNYMERmRWx4R2pTQTVNcG1UcUlLS3A2MTEwZU5uM3VrVVA4eDQ5aw?oc=5","date":"2023-12-05","type":"trial","source":"Clinical Trials Arena","summary":"Technoderma concludes Phase I trial of atopic dermatitis drug - Clinical Trials Arena","headline":"Technoderma concludes Phase I trial of atopic dermatitis drug","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}